ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,953 | -28.2% | 9,079 | -4.7% | 0.01% | -22.2% |
| Q2 2023 | $339,590 | +35.5% | 9,523 | -3.5% | 0.01% | +28.6% |
| Q1 2023 | $250,546 | -35.9% | 9,864 | +2.3% | 0.01% | -36.4% |
| Q4 2022 | $390,958 | +22.6% | 9,639 | 0.0% | 0.01% | +10.0% |
| Q3 2022 | $319,000 | -5.9% | 9,639 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $339,000 | -22.1% | 9,639 | +1.9% | 0.01% | 0.0% |
| Q1 2022 | $435,000 | -29.8% | 9,462 | +1.2% | 0.01% | -27.3% |
| Q4 2021 | $620,000 | +6.2% | 9,350 | 0.0% | 0.01% | -8.3% |
| Q3 2021 | $584,000 | -26.3% | 9,350 | -2.2% | 0.01% | -25.0% |
| Q2 2021 | $792,000 | +22.6% | 9,565 | -1.8% | 0.02% | +14.3% |
| Q1 2021 | $646,000 | -13.5% | 9,740 | 0.0% | 0.01% | -17.6% |
| Q4 2020 | $747,000 | +74.5% | 9,740 | -2.0% | 0.02% | +70.0% |
| Q3 2020 | $428,000 | -3.6% | 9,934 | -3.3% | 0.01% | -9.1% |
| Q2 2020 | $444,000 | +50.0% | 10,277 | 0.0% | 0.01% | +37.5% |
| Q1 2020 | $296,000 | -54.6% | 10,277 | 0.0% | 0.01% | -42.9% |
| Q4 2019 | $652,000 | – | 10,277 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |